Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty.
10.6065/apem.2014.19.1.27
- Author:
Joon Woo BAEK
1
;
Hyo Kyoung NAM
;
Dahee JIN
;
Yeon Joung OH
;
Young Jun RHIE
;
Kee Hyoung LEE
Author Information
1. Department of Pediatrics, Korea University College of Medicine, Seoul, Korea. khlee218@kumc.or.kr
- Publication Type:Original Article
- Keywords:
Gonadotropin-releasing hormone;
Precocious puberty;
Central;
Menarche
- MeSH:
Adult*;
Female;
Gonadotropin-Releasing Hormone*;
Humans;
Medical Records;
Menarche*;
Puberty, Precocious*;
Retrospective Studies
- From:Annals of Pediatric Endocrinology & Metabolism
2014;19(1):27-31
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Gonadotropin-releasing hormone agonist (GnRHa) is known for improving final adult height in patients with central precocious puberty (CPP). This study aimed to investigate the age of menarche and near adult height in girls with CPP who had been treated with GnRHa. METHODS: In this retrospective study, we reviewed the medical records of 71 Korean girls with CPP who had started menarche or reached over 13 years of bone age after long-term GnRHa treatment. We estimated near adult height using the Bayley-Pinneau method and identified the age of menarche in girls with CPP. RESULTS: Mean chronological and bone age at menarche were 11.9+/-0.7 and 12.8+/-0.4 years, respectively. The period between menarche and the end of treatment was 14.0+/-5.6 months. Posttreatment near adult height was 163.8+/-4.7 cm, which was significantly greater than pretreatment predicted adult height (158.7+/-4.1 cm). CONCLUSION: GnRHa treatment in girls with CPP could improve final adult height and made the age of menarche close to that of the general population.
